Pharmacia’s Compliance Program Uses “In-House Prosecutor,” Role-Playing
Pharmacia employs an "in-house prosecutor" to foster an "integrity-based trust building culture," CEO Fred Hassan said
You may also be interested in...
State investigations of pharma manufacturers will present an increasing concern to the industry, Boston Assistant U.S. Attorney Michael Loucks told the Pharmaceutical Regulatory and Compliance Congress in Philadelphia Nov. 13
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials